HopeStage
Back to all studies
CompletedNCT01342380

Genetic and Metabolic Features During Mood-Treatment Studies

About this titleRead the official source — NCT01342380
Observational studyAges 18–70United StatesDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 70 years.

Listed locations
ClevelandSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateFebruary 2011
Recruitment status
Completed
Enrollment listed in the registry
42
Sponsor
University Hospitals Cleveland Medical Center
Sponsor type
University
Study type
Observational
Intervention type
Interview / survey / observational
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT01342380
Official title
Show the full official title

Pharmacogenetic Study of Pioglitazone and Quetiapine XR Treatment Response in Mood Disorders

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Cleveland

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University Hospitals Cleveland Medical Center, a university.

Who was this study for?

Listed age limits: 18 years to 70 years.

Want to explore more studies?

Explore studies